Literature DB >> 18400297

Is everything known in all faces of iceberg in PRAME?

Semra Paydas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18400297     DOI： 10.1016/j.leukres.2008.02.024

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  2 in total

1.  A phase 1 study of a vaccine targeting preferentially expressed antigen in melanoma and prostate-specific membrane antigen in patients with advanced solid tumors.

Authors:  Jeffrey S Weber; Nicholas J Vogelzang; Marc S Ernstoff; Oscar B Goodman; Lee D Cranmer; John L Marshall; Sabrina Miles; Dar Rosario; David C Diamond; Zhiyong Qiu; Mihail Obrocea; Adrian Bot
Journal:  J Immunother       Date:  2011-09       Impact factor: 4.456

2.  The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters.

Authors:  Adalberto Costessi; Nawel Mahrour; Esther Tijchon; Rieka Stunnenberg; Marieke A Stoel; Pascal W Jansen; Dotan Sela; Skylar Martin-Brown; Michael P Washburn; Laurence Florens; Joan W Conaway; Ronald C Conaway; Hendrik G Stunnenberg
Journal:  EMBO J       Date:  2011-08-05       Impact factor: 11.598
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.